Indication
Elderly Subjects With Underlying Diseases
1 clinical trial
1 product
Product
DeuremidevirClinical trial
A Phase 1, Open-label, Single-and Multiple-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of JT001 Administered Orally in Elderly Chinese Subjects With Underlying DiseasesStatus: Completed, Estimated PCD: 2023-08-25